Sophia GeneticsSOPH +0.97%72 Quick Ratio is 1.90 as of Mar. 2026, which is 55% below its 10-year median of 4.19. GuruFocus rates SOPH with a GF Score™ of 72/100 and a GF Value™ of $5.03 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Sophia Genetics ranks better than 66.62% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Sophia Genetics's quick ratio for the quarter that ended in Mar. 2026 was 1.90.
Sophia Genetics has a quick ratio of 1.90. It generally indicates good short-term financial strength.
The historical rank and industry rank for Sophia Genetics's Quick Ratio or its related term are showing as below:
SOPH'
s Quick Ratio Range Over the Past 10 Years
Min: 1.57 Med: 4.19 Max: 10.68
Current: 1.9
During the past 8 years, Sophia Genetics's highest Quick Ratio was 10.68. The lowest was 1.57. And the median was 4.19.
SOPH's Quick Ratio is ranked better than 66.62% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 1.32
vs SOPH: 1.90
Sophia Genetics (NAS:SOPH) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Sophia Genetics Quick Ratio Related Terms
Sophia Genetics Quick Ratio Historical Data
* Premium members only.
The historical data trend for Sophia Genetics's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Sophia Genetics's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sophia Genetics Quick Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sophia Genetics's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Sophia Genetics's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Sophia Genetics's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sophia Genetics (SOPH) has a Quick Ratio of 1.90 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Sophia Genetics and its competitors. This is 55% below median its historical median of 4.19. Over the past decade, Sophia Genetics' Quick Ratio has ranged from 1.57 to 10.68. According to the industry distribution chart, Sophia Genetics ranks #228 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 33.4%.
Is Sophia Genetics' Quick Ratio too high?
Sophia Genetics' current Quick Ratio of 1.90 is 55% below median its 10-year median of 4.19. Over the past 10 years, this metric has ranged from a low of 1.57 to a high of 10.68. The Healthcare Providers & Services industry median Quick Ratio is 1.32. Sophia Genetics' value of 1.90 is 43.9% above this industry median. Based on the distribution chart, Sophia Genetics ranks #228 out of 683 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Sophia Genetics has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sophia Genetics' Quick Ratio compare to SLP and TBRG?
According to the Healthcare Providers & Services industry distribution chart, Sophia Genetics ranks #228 out of 683 companies for Quick Ratio. This puts Sophia Genetics in the upper half of its industry. The industry median Quick Ratio is 1.32. Sophia Genetics' value of 1.90 is 43.9% above this benchmark. Historically, Sophia Genetics' own Quick Ratio has ranged from 1.57 to 10.68 over the past decade. While the company's 10-year median is 4.19 vs. the industry median of 1.32, Sophia Genetics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Healthcare Providers & Services company?
The median Quick Ratio among Healthcare Providers & Services companies is 1.32, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sophia Genetics's current Quick Ratio of 1.90 is 43.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Sophia Genetics and its competitors. For the Healthcare Providers & Services industry, the median Quick Ratio is 1.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sophia Genetics's current Quick Ratio is 1.90, which is 55% below median its own 10-year median of 4.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sophia Genetics stock overvalued right now?
Based on GuruFocus' analysis, Sophia Genetics (SOPH) is currently considered Modestly Overvalued. The stock's GF Value™ is $5.03, compared to a current price of $5.75 — trading 14.3% above its estimated fair value. The current Quick Ratio is 1.90, which is 55% below median its 10-year median of 4.19 and 43.9% above the Healthcare Providers & Services industry median of 1.32. Sophia Genetics' overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Sophia Genetics (SOPH), the current Quick Ratio is 1.90 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sophia Genetics (SOPH) Overvalued in 2026?
Based on GuruFocus' analysis, Sophia Genetics stock appears to be overvalued.
The current stock price of $5.75 is trading 14.3% above its estimated GF Value™ of $5.03.
GuruFocus considers Sophia Genetics to be Modestly Overvalued.
Key valuation signals for SOPH:
Quick Ratio: 1.90 (55% below median its 10-year median of 4.19)
GF Value™: $5.03 vs. price of $5.75 (14.3% above fair value)
Industry Position: 43.9% above the Healthcare Providers & Services median (#228 of 683)
No single metric tells the full story. See the SOPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
72GF Score
Get the complete analysis for SOPH
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SOPH has been successfully added to your 
